springer us feb 2002 (4 Ergebnisse)

Buch. Zustand: Neu. Neuware - Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use. Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use. Non-Myeloablative Allogeneic Transplantation will provide both practitioners and academic clinicians with a better understanding of underlying concepts, current methodologies, and results obtained by the pioneering centers for this rapidly evolving field.

Buch. Zustand: Neu. Neuware - A careful review of the literature covering various aspects of applications of lasers in science and technology reveals that lasers are being applied very widely throughout the entire gamut of physical medicine. After surveying the current developments taking place in the field of medical applications of lasers, it was considered appropriate to bring together these efforts of international research scientists and experts into one volume. It is with this aim that the editors have prepared this volume which brings current research and recent developments to the attention of a wide spectrum of readership associated with hospitals, medical institutions and universities world wide, including also the medical instrument industry. Both teachers and students in the medical faculties will especially find this compendium quite useful. This book is comprised of eleven chapters. All of the important medical applications of lasers are featured. The editors have made every effort that individual chapters are self-contained and written by experts. Emphasis has been placed on straight and simple presentation of the subject matter so that even the new entrants into the field will find the book of value.

Taschenbuch. Zustand: Neu. Neuware - by Maq Mannan President and CEO, DSM Technologies Chairman of the IEEE 1364 Verilog Standards Group Past Chairman of Open Verilog International One of the major strengths of the Verilog language is the Programming Language Interface (PLI), which allows users and Verilog application developers to infinitely extend the capabilities of the Verilog language and the Verilog simulator. In fact, the overwhelming success of the Verilog language can be partly attributed to the exi- ence of its PLI. Using the PLI, add-on products, such as graphical waveform displays or pre and post simulation analysis tools, can be easily developed. These products can then be used with any Verilog simulator that supports the Verilog PLI. This ability to create thi- party add-on products for Verilog simulators has created new markets and provided the Verilog user base with multiple sources of software tools. Hardware design engineers can, and should, use the Verilog PLI to customize their Verilog simulation environment. A Company that designs graphics chips, for ex- ple, may wish to see the simulation results of a new design in some custom graphical display. The Verilog PLI makes it possible, and even trivial, to integrate custom so- ware, such as a graphical display program, into a Verilog simulator. The simulation results can then dynamically be displayed in the custom format during simulation. And, if the company uses Verilog simulators from multiple simulator vendors, this integrated graphical display will work with all the simulators.

Buch. Zustand: Neu. Neuware - This textbook is written at the dawn of a new era in the management of sepsis. Recent achievements in the clinical management of septic shock are the culmination of decades of basic and applied research by innovative researchers and clinical investigators worldwide. The contributing authors to this book have spearheaded much of this research and the Editors have endeavored to create a textbook that is comprehensive in nature while maintaining a specific focus upon the multitude of work that constitutes the spectrum of sepsis research including: pathophysiology; monitoring systems; general support; microbial aspects; complications; and anti-sepsis therapies.